Carnegie Investment Counsel Grows Stake in Relx Plc $RELX

Carnegie Investment Counsel lifted its position in Relx Plc (NYSE:RELX) by 14.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 362,560 shares of the technology company’s stock after buying an additional 44,646 shares during the period. Carnegie Investment Counsel’s holdings in Relx were worth $19,702,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Larson Financial Group LLC boosted its stake in shares of Relx by 612.5% in the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company’s stock worth $26,000 after buying an additional 441 shares during the last quarter. WPG Advisers LLC purchased a new position in shares of Relx in the 1st quarter worth $28,000. Golden State Wealth Management LLC lifted its position in Relx by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company’s stock valued at $30,000 after purchasing an additional 294 shares in the last quarter. Harbor Asset Planning Inc. purchased a new position in Relx during the second quarter valued at $37,000. Finally, Cornerstone Planning Group LLC lifted its position in Relx by 325.2% during the first quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company’s stock valued at $37,000 after purchasing an additional 530 shares in the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on RELX shares. Weiss Ratings restated a “buy (b)” rating on shares of Relx in a research report on Wednesday, October 8th. Barclays restated an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. Kepler Capital Markets upgraded Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Wall Street Zen downgraded Relx from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Finally, Morgan Stanley restated an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. One investment analyst has rated the stock with a Strong Buy rating and five have assigned a Buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy”.

Relx Trading Down 1.9%

RELX opened at $45.89 on Friday. The stock has a market cap of $83.86 billion, a price-to-earnings ratio of 24.67, a P/E/G ratio of 3.07 and a beta of 0.87. The stock’s 50 day moving average price is $46.65 and its 200-day moving average price is $50.55. Relx Plc has a one year low of $44.19 and a one year high of $56.33. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.